BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Pilocarpine

A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.

297+ PubMed studies analyzed · 20 RCTs · Evidence Score: 43.8

Research Domains

Pilocarpine has been studied across 16 research domains including 👁️ Vision & Eye, 🧠 Focus & Attention, 🔬 Oncology, ❤️ Cardiovascular, 🫁 Liver & Detox. The primary research focus is 👁️ Vision & Eye with 23% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pilocarpine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Scopolamine
7 shared targets
tropicamide
7 shared targets
Hyoscyamine
9 shared targets
Muscarine
7 shared targets
Ipratropium
6 shared targets
N-Methylscopolamine
6 shared targets
Butaclamol
7 shared targets
carbachol
5 shared targets
pirenzepine
5 shared targets
oxotremorine
5 shared targets
Loading evidence profile...

This evidence profile for Pilocarpine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.